{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:06:11Z","timestamp":1793318771427,"version":"4.5.0"},"reference-count":196,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Evidence demonstrated that bones, liver, and lungs are the most common metastasis sites in some human malignancies, especially in prostate and breast cancers. Bone is the third most frequent target for spreading tumor cells among these organs and tissues. Patients with bone-metastatic cancers face a grim prognosis characterized by short median survival time. Current treatments have proven insufficient, as they can only inhibit metastasis or tumor progression within the bone tissues rather than providing a curative solution. Gaining a more profound comprehension of the interplay between tumor cells and the bone microenvironment (BME) is of utmost importance in tackling this issue. This knowledge will pave the way for developing innovative diagnostic and therapeutic approaches. This review summarizes the mechanisms underlying bone metastasis and discusses the clinical aspects of this pathologic condition. Additionally, it highlights emerging therapeutic interventions aimed at enhancing the quality of life for patients affected by bone-metastatic cancers. By synthesizing current research, this review seeks to shed light on the complexities of bone metastasis and offer insights for future advancements in patient care.<\/jats:p>","DOI":"10.3389\/fendo.2023.1260491","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T04:44:57Z","timestamp":1704689097000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers"],"prefix":"10.3389","volume":"14","author":[{"given":"Huanrong","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"106896","DOI":"10.1016\/j.phrs.2023.106896","article-title":"Chromatin accessibility dynamics in colorectal cancer liver metastasis: Uncovering the liver tropism at single cell resolution","volume":"195","author":"Li","year":"2023","journal-title":"Pharmacol Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-023-01805-y","article-title":"Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer","volume":"22","author":"Ye","year":"2023","journal-title":"Mol Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00990","article-title":"Combination of immunotherapy with targeted therapy: theory and practice in metastatic melanoma","volume":"10","author":"Yu","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-020-01447-w","article-title":"Steps in metastasis: an updated review","volume":"38","author":"Majidpoor","year":"2021","journal-title":"Med Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/biomedicines10020300","article-title":"Cooperation between angiogenesis, vasculogenesis, chemotaxis, and coagulation in breast cancer metastases development: pathophysiological point of view","volume":"10","author":"Zarychta","year":"2022","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12964-022-00951-y","article-title":"The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors","volume":"20","author":"Zalpoor","year":"2022","journal-title":"Cell Communication Signaling"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.euus.2005.09.006","article-title":"Molecular and biological mechanisms of bone metastasis","volume":"3","author":"Cecchini","year":"2005","journal-title":"EAU Update Ser"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the hallmarks of metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4081\/oncol.2017.321","article-title":"Bone metastases: an overview","volume":"11","author":"Macedo","year":"2017","journal-title":"Oncol Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/cancers14061580","article-title":"Addressing the elephant in the immunotherapy room: effector T-cell priming versus depletion of regulatory T-cells by anti-CTLA-4 therapy","volume":"14","author":"Hong","year":"2022","journal-title":"Cancers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-023-00373-7","article-title":"Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment","volume":"12","author":"Yan","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2012.07.013","article-title":"Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid","volume":"1820","author":"Dedes","year":"2012","journal-title":"Biochim Biophys Acta (BBA)-General Subj"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/1758834011412656","article-title":"Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion","volume":"3","author":"Steger","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(01)00092-0","article-title":"Novel therapeutic approaches to cancer patients with bone metastasis","volume":"40","author":"Maisano","year":"2001","journal-title":"Crit Rev oncology\/hematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal transduction targeted Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00300-6","article-title":"Cancer progression and the invisible phase of metastatic colonization","volume":"20","author":"Klein","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"a036905","DOI":"10.1101\/cshperspect.a036905","article-title":"Cancer stem cells and epithelial-to-mesenchymal transition in cancer metastasis","volume":"10","author":"Celi\u00e0-Terrassa","year":"2020","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.3390\/cancers12103067","article-title":"Therapy resistance, cancer stem cells and ECM in cancer: the matrix reloaded","volume":"12","author":"Kesh","year":"2020","journal-title":"Cancers"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00966-3","article-title":"Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment","volume":"13","author":"L\u00f3pez de Andr\u00e9s","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2200039","DOI":"10.1002\/adbi.202200039","article-title":"The role of ECM remodeling, EMT, and adhesion molecules in cancerous neural invasion: changing perspectives","volume":"6","author":"Mukherjee","year":"2022","journal-title":"Advanced Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"jcs231563","DOI":"10.1242\/jcs.231563","article-title":"Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential","volume":"132","author":"Allen","year":"2019","journal-title":"J Cell Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/PAP.0000000000000219","article-title":"Paget\u2019s \u201cseed and soil\u201d theory of cancer metastasis: an idea whose time has come","volume":"26","author":"Akhtar","year":"2019","journal-title":"Adv anatomic Pathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43556-020-00022-z","article-title":"Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways","volume":"2","author":"Wang","year":"2021","journal-title":"Mol biomed"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12370","article-title":"Cancer metastasis: Mechanisms of inhibition by melatonin","volume":"62","author":"Su","year":"2017","journal-title":"J pineal Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/j.tranon.2020.100909","article-title":"Transitional dynamics of cancer stem cells in invasion and metastasis","volume":"14","author":"Richard","year":"2021","journal-title":"Trans Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41416-020-01150-7","article-title":"Metastasis: crosstalk between tissue mechanics and tumour cell plasticity","volume":"124","author":"Coban","year":"2021","journal-title":"Br J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-022-00666-2","article-title":"Adjuvant therapy options in renal cell carcinoma\u2014targeting the metastatic cascade","volume":"20","author":"Fitzgerald","year":"2023","journal-title":"Nat Rev Urol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"188867","DOI":"10.1016\/j.bbcan.2023.188867","article-title":"Metastasis prevention: How to catch metastatic seeds","author":"Gerashchenko","year":"2023","journal-title":"Biochim Biophys Acta (BBA)-Reviews Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.5858\/2008-132-931-MPOCRF","article-title":"Metastatic patterns of cancers: results from a large autopsy study","volume":"132","author":"Disibio","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: a population-based analysis","volume":"74","author":"Gandaglia","year":"2014","journal-title":"Prostate"},{"key":"B34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","article-title":"Metastatic sites and survival in lung cancer","volume":"86","author":"Riihim\u00e4ki","year":"2014","journal-title":"Lung Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1102\/1470-7330.2013.0011","article-title":"Typical and atypical metastatic sites of recurrent endometrial carcinoma","volume":"13","author":"Kurra","year":"2013","journal-title":"Cancer Imaging"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann Oncol"},{"key":"B37","first-page":"816","article-title":"Unusual extrahepatic metastatic sites from hepatocellular carcinoma","volume":"6","author":"Terada","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"Kennecke","year":"2010","journal-title":"J Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6311-z","article-title":"The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-08100-5","article-title":"The impact of primary tumor location in synchronous metastatic colorectal cancer: differences in metastatic sites and survival","volume":"27","author":"Brouwer","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1159\/000055740","article-title":"Incidence and sites of distant metastases from head and neck cancer","volume":"63","author":"Ferlito","year":"2001","journal-title":"ORL"},{"key":"B42","doi-asserted-by":"publisher","first-page":"E148","DOI":"10.5489\/cuaj.787","article-title":"Age-stratified distribution of metastatic sites in bladder cancer: a population-based analysis","volume":"8","author":"Bianchi","year":"2014","journal-title":"Can Urological Assoc J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00402","article-title":"Does cancer of unknown primary (CUP) truly exist as a distinct cancer entity","volume":"9","author":"Bochtler","year":"2019","journal-title":"Front Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"53245","DOI":"10.18632\/oncotarget.10644","article-title":"Prognostic effect of liver metastasis in lung cancer patients with distant metastasis","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"B45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41571-021-00499-9","article-title":"Novel approaches to target the microenvironment of bone metastasis","volume":"18","author":"Hofbauer","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jdsr.2007.11.002","article-title":"Roles of Wnt signaling in bone formation and resorption","volume":"44","author":"Kobayashi","year":"2008","journal-title":"Japanese Dental Sci Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"155559","DOI":"10.1016\/j.cyto.2021.155559","article-title":"The hidden secrets of soluble RANKL in bone biology","volume":"144","author":"Elango","year":"2021","journal-title":"Cytokine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"116353","DOI":"10.1016\/j.bone.2022.116353","article-title":"RANKL biology","volume":"159","author":"Takegahara","year":"2022","journal-title":"Bone"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2017.11.003","article-title":"Bone mesenchymal stem cell secretion of sRANKL\/OPG\/M-CSF in response to macrophage-mediated inflammatory response influences osteogenesis on nanostructured Ti surfaces","volume":"154","author":"Ma","year":"2018","journal-title":"Biomaterials"},{"key":"B51","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jbmr.1547","article-title":"Osteocyte RANKL: new insights into the control of bone remodeling","volume":"27","author":"Xiong","year":"2012","journal-title":"J Bone Mineral Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/jcm8060836","article-title":"Parathyroid hormone-related protein (PTHrP) accelerates soluble RANKL signals for downregulation of osteogenesis of bone mesenchymal stem cells","volume":"8","author":"Elango","year":"2019","journal-title":"J Clin Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/10408369509084687","article-title":"Parathyroid hormone-related protein","volume":"32","author":"Moseley","year":"1995","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B54","volume-title":"Handbook of hormones: comparative endocrinology for basic and clinical research","author":"Ando","year":"2021"},{"key":"B55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/jcem.81.1.8550752","article-title":"Parathyroid hormone (PTH)-related protein (1-36) is equipotent to PTH (1-34) in humans","volume":"81","author":"Everhart-Caye","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.3.900","article-title":"Parathyroid hormone-related protein-(1\u201336) is biologically active when administered subcutaneously to humans","volume":"82","author":"Henry","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.8.5047","article-title":"Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1\u201336) in humans: potential as an anabolic therapy for osteoporosis","volume":"83","author":"Plotkin","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.040709","article-title":"PTHrP prevents chondrocyte premature hypertrophy by inducing cyclin-D1-dependent Runx2 and Runx3 phosphorylation, ubiquitylation and proteasomal degradation","volume":"122","author":"Zhang","year":"2009","journal-title":"J Cell Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"439","DOI":"10.21037\/tlcr-20-835","article-title":"Current progress and mechanisms of bone metastasis in lung cancer: a narrative review","volume":"10","author":"Wu","year":"2021","journal-title":"Trans Lung Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0309","article-title":"The role of IL-1B in breast cancer bone metastasis","volume":"25","author":"Tulotta","year":"2018","journal-title":"Endocrine-related Cancer"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3390\/ijms20102587","article-title":"Prostate cancer and bone metastases: the underlying mechanisms","volume":"20","author":"Wong","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1677\/ERC-07-0229","article-title":"Bone metastases from differentiated thyroid carcinoma","volume":"15","author":"Muresan","year":"2008","journal-title":"Endocrine-related Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015599831232","article-title":"Prostate carcinoma skeletal metastases: cross-talk between tumor and bone","volume":"20","author":"Keller","year":"2001","journal-title":"Cancer Metastasis Rev"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(02)02340-7","article-title":"Transcription factors in bone: developmental and pathological aspects","volume":"8","author":"Yang","year":"2002","journal-title":"Trends Mol Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1127637","article-title":"The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.03.011","article-title":"Management of bone metastases in cancer: a review","volume":"56","author":"Selvaggi","year":"2005","journal-title":"Crit Rev oncology\/hematol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/14737140.2020.1807950","article-title":"Osteolytic metastasis in breast cancer: effective prevention strategies","volume":"20","author":"Mandal","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.02.177","article-title":"Endogenous parathyroid hormone (PTH) signals through osteoblasts via RANKL during fracture healing to affect osteoclasts","volume":"525","author":"Sun","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B69","article-title":"The role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastases","volume-title":"Seminars in oncology","author":"Coleman","year":"2001"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-020-00105-1","article-title":"Molecular mechanisms and clinical management of cancer bone metastasis","volume":"8","author":"Wang","year":"2020","journal-title":"Bone Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1593\/neo.04646","article-title":"Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs","volume":"7","author":"Glinskii","year":"2005","journal-title":"Neoplasia"},{"key":"B74","article-title":"Expression of cyclooxygenase 2 in human Malignant melanoma","volume":"61","author":"Denkert","year":"2001","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-021-09974-2","article-title":"The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers","volume":"40","author":"Midavaine","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.591386","article-title":"CXCR4 and CXCR7 signaling pathways: a focus on the cross-talk between cancer cells and tumor microenvironment","volume":"11","author":"Santagata","year":"2021","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.574667","article-title":"The role of the CXCL12\/CXCR4\/CXCR7 chemokine axis in cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Front Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-12-0361","article-title":"The lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferationXCR1 in ovarian carcinoma","volume":"10","author":"Kim","year":"2012","journal-title":"Mol Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2009.04.013","article-title":"Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion","volume":"284","author":"Pinilla","year":"2009","journal-title":"Cancer Lett"},{"key":"B80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/pros.20500","article-title":"Expression and activation of \u03b1v\u03b23 integrins by SDF-1\/CXC12 increases the aggressiveness of prostate cancer cells","volume":"67","author":"Sun","year":"2007","journal-title":"Prostate"},{"key":"B81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/pros.20318","article-title":"CXCL12\/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12","volume":"66","author":"Chinni","year":"2006","journal-title":"Prostate"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157917","article-title":"IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer","volume":"132","author":"He","year":"2022","journal-title":"J Clin Invest"},{"key":"B84","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.153890","article-title":"Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways","volume":"285","author":"Krause","year":"2010","journal-title":"J Biol Chem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.307","article-title":"Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones","volume":"26","author":"Ominsky","year":"2011","journal-title":"J Bone Mineral Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1111\/cas.15765","article-title":"Sclerostin blockade promotes bone metastases of Wnt-responsive breast cancer cells","volume":"114","author":"Hiraga","year":"2023","journal-title":"Cancer Sci"},{"key":"B88","first-page":"949","article-title":"LncRNA TEX41 regulates autophagy by increasing Runx2 expression in lung adenocarcinoma bone metastasis","volume":"15","author":"Li","year":"2023","journal-title":"Am J Trans Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005532","article-title":"BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer","volume":"11","author":"Yin","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41419-021-03928-w","article-title":"Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p\/RAC1 signalling axis in osteoclasts","volume":"12","author":"Ni","year":"2021","journal-title":"Cell Death Dis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13823","article-title":"Exosomal lncRNA HOTAIR promotes osteoclast differentiation by targeting TGF-\u03b2\/PTHrP\/RANKL pathway","volume":"132","author":"Zhang","year":"2023","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"101901","DOI":"10.1016\/j.mcp.2023.101901","article-title":"Identification of miR-1-3p, miR-143\u20133p and miR-145\u20135p association with bone metastasis of Gleason 3+ 4 prostate cancer and involvement of LASP1 regulation","volume":"68","author":"Guo","year":"2023","journal-title":"Mol Cell Probes"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.52","article-title":"Clinical course and prognostic factors following bone recurrence from breast cancer","volume":"77","author":"Coleman","year":"1998","journal-title":"Br J Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"Br J Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70364-6","article-title":"How is androgen-dependent metastatic prostate cancer best treated","volume":"10","author":"Robson","year":"1996","journal-title":"Hematology\/Oncol Clinics"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11144","article-title":"Bone cancer pain","volume":"97","author":"Clohisy","year":"2003","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2020.07.014","article-title":"Radiofrequency ablation for the palliative treatment of bone metastases: outcomes from the multicenter OsteoCool Tumor Ablation Post-Market Study (OPuS One Study) in 100 patients","volume":"31","author":"Levy","year":"2020","journal-title":"J Vasc Interventional Radiol"},{"key":"B98","article-title":"Multiple Myeloma presenting as Hypercalcemic Crisis: A case report","volume":"24","author":"Annadatha","year":"2020","journal-title":"Med Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-22254-3_13","article-title":"Parathyroid hormone-related protein (PTHrP): an emerging target in cancer progression and metastasis","author":"Zhang","year":"2019","journal-title":"Hum Cell Transformation"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.12.006","article-title":"Mechanisms of hypercalcemia in non-Hodgkin lymphoma and associated outcomes: a retrospective review","volume":"18","author":"Shallis","year":"2018","journal-title":"Clin Lymphoma Myeloma Leukemia"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-196511000-00015","article-title":"The management of pathological fractures","volume":"5","author":"Higinbotham","year":"1965","journal-title":"J Trauma Acute Care Surg"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyz028","article-title":"Early detection of bone metastases of hepatocellular carcinoma reduces bone fracture and paralysis","volume":"49","author":"Hirai","year":"2019","journal-title":"Japanese J Clin Oncol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu103","article-title":"Bone health in cancer patients: ESMO Clinical Practice Guidelines","volume":"25","author":"Coleman","year":"2014","journal-title":"Ann Oncol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0305-7372(96)90021-3","article-title":"Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment","volume":"22","author":"Vinholes","year":"1996","journal-title":"Cancer Treat Rev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1053\/crad.2000.0417","article-title":"Magnetic resonance imaging versus radionuclide scintigraphy for screening in bone metastases","volume":"55","author":"Evans","year":"2000","journal-title":"Clin Radiol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1595::AID-CNCR10>3.0.CO;2-V","article-title":"Radiologic diagnosis of bone metastases","volume":"80","author":"Rosenthal","year":"1997","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"B107","doi-asserted-by":"crossref","DOI":"10.1053\/j.semnuclmed.2004.11.005","article-title":"Positron emission tomography and bone metastases","volume-title":"Semin Nucl Med","author":"Fogelman","year":"2005"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.199.3.8638000","article-title":"Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18] fluoro-D-glucose","volume":"199","author":"Shreve","year":"1996","journal-title":"Radiology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2967\/jnumed.119.234260","article-title":"Molecular imaging of bone metastases and their response to therapy","volume":"61","author":"Cook","year":"2020","journal-title":"J Nucl Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"109020","DOI":"10.1016\/j.ejrad.2020.109020","article-title":"A Radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients","volume":"128","author":"Zhang","year":"2020","journal-title":"Eur J Radiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"115101","DOI":"10.1016\/j.bone.2019.115101","article-title":"Patient-specific finite element computer models improve fracture risk assessments in cancer patients with femoral bone metastases compared to clinical guidelines","volume":"130","author":"Eggermont","year":"2020","journal-title":"Bone"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-022-02144-6","article-title":"The role of surgery in the treatment of metastatic bone tumor","volume":"27","author":"Hayashi","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1614::AID-CNCR12>3.0.CO;2-2","article-title":"Orthopedic surgical management of skeletal complications of Malignancy","volume":"80","author":"Harrington","year":"1997","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s00590-015-1726-y","article-title":"Palliative embolization for metastases of the spine","volume":"26","author":"Facchini","year":"2016","journal-title":"Eur J Orthopaedic Surg Traumatol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11547-012-0802-4","article-title":"Embolisation of bone metastases from renal cancer","volume":"118","author":"Rossi","year":"2013","journal-title":"La radiologia Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1302\/2058-5241.5.190013","article-title":"Preoperative embolization in surgical treatment of long bone metastasis: a systematic literature review","volume":"5","author":"Geraets","year":"2020","journal-title":"EFORT Open Rev"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399408000616","article-title":"Molecular mechanisms and treatment of bone metastasis","volume":"10","author":"Clines","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4002-1","article-title":"Surgical management of bone metastases: quality of evidence and systematic review","volume":"21","author":"Wood","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-021-02764-w","article-title":"Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis","volume":"24","author":"Deodato","year":"2022","journal-title":"Clin Trans Oncol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006250213357","article-title":"Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer","volume":"56","author":"Pyrh\u00f6nen","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3909\/riu0547","article-title":"LHRH agonists for the treatment of prostate cancer: 2012","volume":"14","author":"Lepor","year":"2012","journal-title":"Rev Urol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14614","article-title":"Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study","volume":"28","author":"Nakajima","year":"2021","journal-title":"Int J Urol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0167-8140(94)90411-1","article-title":"A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer","volume":"31","author":"Quilty","year":"1994","journal-title":"Radiother Oncol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2012.96","article-title":"The role of TGF-\u03b2 in bone metastasis: novel therapeutic perspectives","volume":"1","author":"Buijs","year":"2012","journal-title":"BoneKEy Rep"},{"key":"B128","article-title":"Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment","volume-title":"Semin Oncol","author":"Mundy","year":"2001"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.6353","article-title":"Association of osteonecrosis of the jaw with zoledronic acid treatment for bone metastases in patients with cancer","volume":"7","author":"Van Poznak","year":"2021","journal-title":"JAMA Oncol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2636","article-title":"CXCL12 (SDF1\u03b1)-CXCR4\/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Anti-CXCL12 therapy in solid cancers","volume":"17","author":"Duda","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0184-1","article-title":"Transforming growth factor-\u03b2 signaling: emerging stem cell target in metastatic breast cancer","volume":"115","author":"Tan","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-06-0235","article-title":"Inhibiting hypoxia-inducible factor 1 for cancer therapy","volume":"4","author":"Melillo","year":"2006","journal-title":"Mol Cancer Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/molecules25102380","article-title":"Ras and Wnt interaction contribute in prostate cancer bone metastasis","volume":"25","author":"Lin","year":"2020","journal-title":"Molecules"},{"key":"B135","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting metastatic cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nat Med"},{"key":"B136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-58339-2","article-title":"Dynamic changes of receptor activator of nuclear factor-\u03baB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer","volume":"10","author":"Pantano","year":"2020","journal-title":"Sci Rep"},{"key":"B137","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11096-020-01105-1","article-title":"Meta-analysis of clinical trials to assess denosumab over zoledronic acid in bone metastasis","volume":"43","author":"Chen","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"B138","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"2015","author":"Gnant","year":"9992","journal-title":"Lancet"},{"key":"B139","doi-asserted-by":"publisher","first-page":"119558","DOI":"10.1016\/j.biomaterials.2019.119558","article-title":"Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis","volume":"227","author":"Vijayaraghavalu","year":"2020","journal-title":"Biomaterials"},{"key":"B140","doi-asserted-by":"publisher","first-page":"119791","DOI":"10.1016\/j.biomaterials.2020.119791","article-title":"Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis","volume":"240","author":"Landgraf","year":"2020","journal-title":"Biomaterials"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1039\/D0TB00046A","article-title":"Alendronate\/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer","volume":"8","author":"Chen","year":"2020","journal-title":"J materials Chem B"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24564-0","article-title":"Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nat Commun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191820","article-title":"Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth","volume":"217","author":"Ma","year":"2020","journal-title":"J Exp Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"125667","DOI":"10.1016\/j.cej.2020.125667","article-title":"Bone-targeted oxidative stress nanoamplifier for synergetic chemo\/chemodynamic therapy of bone metastases through increasing generation and reducing elimination of ROS","volume":"399","author":"Huang","year":"2020","journal-title":"Chem Eng J"},{"key":"B145","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.7150\/thno.42218","article-title":"Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.12.043","article-title":"A light-triggered self-reinforced nanoagent for targeted chemo-photodynamic therapy of breast cancer bone metastases via ER stress and mitochondria mediated apoptotic pathways","volume":"319","author":"Huang","year":"2020","journal-title":"J Controlled Release"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15429-z","article-title":"Differential regulation of breast cancer bone metastasis by PARP1 and PARP2","volume":"11","author":"Zuo","year":"2020","journal-title":"Nat Commun"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.08.068","article-title":"Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors","volume":"164","author":"Wu","year":"2020","journal-title":"Int J Biol Macromolecules"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00069","article-title":"The CaSR in pathogenesis of breast cancer: a new target for early stage bone metastases","volume":"10","author":"Das","year":"2020","journal-title":"Front Oncol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.7150\/thno.45351","article-title":"Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells","volume":"11","author":"Yuan","year":"2021","journal-title":"Theranostics"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21976-w","article-title":"Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4790","article-title":"Radium-223 treatment increases immune checkpoint expression in extracellular vesicles from the metastatic prostate cancer bone microenvironment","volume":"27","author":"Vardaki","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4476","article-title":"Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate CancerSipuleucel-T plus Radium in mCRPC","volume":"27","author":"Marshall","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.7150\/thno.40489","article-title":"SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32554","article-title":"GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer","volume":"146","author":"Sawada","year":"2020","journal-title":"Int J Cancer"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15155","article-title":"Sphingosine-1-phosphate (S1P) receptors: promising drug targets for treating bone-related diseases","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"113943","DOI":"10.1016\/j.bcp.2020.113943","article-title":"PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling","volume":"177","author":"Verma","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2021200101","article-title":"Cryoablation for palliation of painful bone metastases: the MOTION multicenter study","volume":"3","author":"Jennings","year":"2021","journal-title":"Radiology: Imaging Cancer"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00978","article-title":"Lutetium177-Labeled DOTA-Ibandronate: a novel radiopharmaceutical for targeted treatment of bone metastases","volume":"20","author":"Wang","year":"2023","journal-title":"Mol Pharmaceutics"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12645-023-00200-y","article-title":"Targeting nano-regulator based on metal\u2013organic frameworks for enhanced immunotherapy of bone metastatic prostate cancer","volume":"14","author":"Huang","year":"2023","journal-title":"Cancer Nanotechnol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2023.05.038","article-title":"Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression","volume":"166","author":"Liu","year":"2023","journal-title":"Acta Biomaterialia"},{"key":"B162","doi-asserted-by":"publisher","first-page":"MCR","DOI":"10.1158\/1541-7786.MCR-22-0695","article-title":"Targeting c-Jun is a potential therapy for luminal breast cancer bone metastasis","volume":"21","author":"Han","year":"2023","journal-title":"Mol Cancer Res"},{"key":"B163","doi-asserted-by":"publisher","first-page":"2207080","DOI":"10.1002\/advs.202207080","article-title":"Bone lesion-derived extracellular vesicles fuel prometastatic cascades in hepatocellular carcinoma by transferring ALKBH5-targeting miR-3190-5p","volume":"10","author":"Han","year":"2023","journal-title":"Advanced Sci"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-023-02763-4","article-title":"Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer","volume":"21","author":"Huang","year":"2023","journal-title":"BMC Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.11.044","article-title":"Combining dual-targeted liquid metal nanoparticles with autophagy activation and mild photothermal therapy to treat metastatic breast cancer and inhibit bone destruction","volume":"157","author":"Shen","year":"2023","journal-title":"Acta Biomaterialia"},{"key":"B166","doi-asserted-by":"publisher","first-page":"116630","DOI":"10.1016\/j.bone.2022.116630","article-title":"SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-\u03baB signaling pathway","volume":"167","author":"Wu","year":"2023","journal-title":"Bone"},{"key":"B167","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13018-022-03473-y","article-title":"GPR84 potently inhibits osteoclastogenesis and alleviates osteolysis in bone metastasis of colorectal cancer","volume":"18","author":"Jian","year":"2023","journal-title":"J Orthopaedic Surg Res"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0583","article-title":"A phase I study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer (mCRPC) with bone metastases (COMRADE)","volume":"22","author":"Pan","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"B169","doi-asserted-by":"publisher","first-page":"114390","DOI":"10.1016\/j.biopha.2023.114390","article-title":"Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases","volume":"160","author":"Inagaki","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B170","doi-asserted-by":"publisher","first-page":"107261","DOI":"10.1016\/j.lungcan.2023.107261","article-title":"Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312)","volume":"182","author":"Katakami","year":"2023","journal-title":"Lung Cancer"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.5843","article-title":"Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: The FAST-01 nonrandomized trial","volume":"9","author":"Mascia","year":"2023","journal-title":"JAMA Oncol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"2104645","DOI":"10.1002\/adfm.202104645","article-title":"Self-delivered supramolecular nanomedicine with transformable shape for ferrocene-amplified photodynamic therapy of breast cancer and bone metastases","volume":"31","author":"Qin","year":"2021","journal-title":"Advanced Funct Materials"},{"key":"B173","doi-asserted-by":"publisher","first-page":"120345","DOI":"10.1016\/j.biomaterials.2020.120345","article-title":"Bone-targeting polymer vesicles for simultaneous imaging and effective Malignant bone tumor treatment","volume":"269","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"B174","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1200\/JCO.19.01638","article-title":"Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study","volume":"38","author":"Antonarakis","year":"2020","journal-title":"J Clin Oncol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-020-01847-y","article-title":"Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis","volume":"26","author":"Guo","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13146","article-title":"Dual inhibition of TGF-\u03b2 and PD-L1: a novel approach to cancer treatment","volume":"16","author":"Gulley","year":"2022","journal-title":"Mol Oncol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.3390\/cancers13123076","article-title":"The role of extracellular vesicles in disease progression and detection of hepatocellular carcinoma","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41467-021-21976-w","article-title":"Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2014.75","article-title":"Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC)","volume":"3","author":"Confavreux","year":"2014","journal-title":"BoneKEy Rep"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00774-022-01396-6","article-title":"Circulating biomarkers for diagnosis and therapeutic monitoring in bone metastasis","author":"Song","year":"2023","journal-title":"J Bone Mineral Metab"},{"key":"B181","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbrc.2015.05.092","article-title":"Spondin 1 promotes metastatic progression through Fak and Src dependent pathway in human osteosarcoma","volume":"464","author":"Chang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B182","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/jcmm.14618","article-title":"Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells","volume":"24","author":"Lu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.9b00273","article-title":"Near-infrared photoimmunotherapy of cancer","volume":"52","author":"Kobayashi","year":"2019","journal-title":"Accounts Chem Res"},{"key":"B184","doi-asserted-by":"publisher","first-page":"120404","DOI":"10.1016\/j.biomaterials.2020.120404","article-title":"Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges","volume":"265","author":"Gao","year":"2021","journal-title":"Biomaterials"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2697","article-title":"Bad to the bone: the role of the insulin-like growth factor axis in osseous metastasis","volume":"25","author":"Rieunier","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B186","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.3390\/cancers13164229","article-title":"Recent advances in the treatment of bone metastases and primary bone tumors: An up-to-date review","volume":"13","author":"B\u0103dil\u0103","year":"2021","journal-title":"Cancers"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0931","article-title":"Targeted therapy to \u03b23 integrin reduces chemoresistance in breast cancer bone metastases","volume":"20","author":"Fox","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.175","article-title":"Contribution of bone microenvironment to leukemogenesis and leukemia progression","volume":"23","author":"Ayala","year":"2009","journal-title":"Leukemia"},{"key":"B189","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1158\/0008-5472.CAN-11-2681","article-title":"Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment","volume":"72","author":"Heller","year":"2012","journal-title":"Cancer Res"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1159\/000082923","article-title":"The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer","volume":"67","author":"Delea","year":"2005","journal-title":"Oncology"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.0.CO;2-Q","article-title":"The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma","volume":"88","author":"Carlin","year":"2000","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01394-8","article-title":"Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-\u03baB\/bone remodeling factors signaling","volume":"20","author":"Xu","year":"2021","journal-title":"Mol Cancer"},{"key":"B193","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41571-018-0134-8","article-title":"A framework for the development of effective anti-metastatic agents","volume":"16","author":"Anderson","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"101784","DOI":"10.1016\/j.media.2020.101784","article-title":"Automated diagnosis of bone metastasis based on multi-view bone scans using attention-augmented deep neural networks","volume":"65","author":"Pi","year":"2020","journal-title":"Med Image Anal"},{"key":"B195","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2147\/ORR.S379603","article-title":"Management of long bones metastatic disease: concepts that we all know but not always remember","volume":"14","author":"Gonzalez","year":"2022","journal-title":"Orthopedic Res Rev"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14193","article-title":"Diagnosis and treatment of melanoma bone metastasis: A multidisciplinary approach","volume":"33","author":"Caldaria","year":"2020","journal-title":"Dermatologic Ther"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1260491\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T04:45:09Z","timestamp":1704689109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1260491\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":196,"alternative-id":["10.3389\/fendo.2023.1260491"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1260491","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"article-number":"1260491"}}